Grove Biopharma
United States
activeunknown
unknown
Stage
2024
Founded
1
Investors
About
Grove Biopharma develops synthetic brush-like molecules called precision-linked proteomimetics designed to penetrate cell membranes and modulate intracellular protein-protein interactions to treat cancer and other diseases.
Explore Grove Biopharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.